Company Overview
- Website
- innervace.com
- Employees
- 3
- Founded in
- 2020
- Industry
- BioTech/Drugs
- SIC Code
-
8731 - Commercial Physical and Biological Research
Financials & Stats
Revenue
$3B
Recent News & Media
Biotech company spin-off from Penn raises $40 million for Parkinson's disease research
- Sep 28, 2022
- thedp.com
Bioengineer takes big step forward in radical approach to treating neurodegeneration
- May 29, 2018
- penntoday.upenn.edu
Who is Innervace
Innervace is a small regenerative therapy company based in New York, New York, with a team of four employees. The company focuses on developing innovative technologies for treating neurological conditions. Innervace specializes in creating implantable tissue pathways designed to restore lost neural connections caused by brain injury or degeneration. Their primary program aims to address the degeneration of the nigrostriatal pathway, a key pathway affected in patients with Parkinson's disease (PD). What sets Innervace apart is its unique approach to regenerative therapy. The company's technology utilizes pre-formed, anatomically-inspired tissue pathways, providing a direct replacement for lost connections within the brain. This innovative method offers a potentially transformative solution for patients suffering from neurological disorders. For more information about Innervace and its groundbreaking research, please visit their website at innervace.com.
Company Leadership
Innervace Industry Tags
Companies Similar to Innervace
Analyze industry trends and opportunities by examining competitors and companies comparable to Innervace, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 2 | Cambridge, MA | 2005 | |
| 3M | 7 | New York, NY | 2008 | |
| 3M | 3 | New York, NY | ||
| 3M | 2 | Knoxville, TN | 2004 | |
| 3M | 35 | Austin, TX |